William A. Backus - 01 Apr 2022 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Dec 2022, 15:15:19 UTC
Prior SEC filing
16 Feb 2022
Next SEC filing
10 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Hatsuki Miyata, Attorney-in-Fact for William A. Backus

Key filing fact

William A. Backus filed Form 4 for BALCHEM CORP (BCPC) on 30 Dec 2022.

Key facts

  • This page summarizes William A. Backus's Form 4 filing for BALCHEM CORP (BCPC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Dec 2022, 15:15.

Change

  • Previous filing in this sequence was filed on 16 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+750
Change %
+7.6%
Price
$0.000000
Shares after
10,655
Date
01 Apr 2022
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This is an inadvertent late filing due to an administrative error.

Footnote F2

Ownership of restricted stock vests in Reporting Person in 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Footnote F3

Includes acquisition of shares under the Balchem Corporation 401(k) plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .